All In Biotech

Drug Trial Radar · NCT07607483

A Study of LY4065967 in Healthy Participants

A Phase 1, Randomized, Open-Label, Crossover Study to Investigate the Relative Bioavailability of LY4065967 Formulations in Healthy Participants

Last checked: Nov 19, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

Jun 3, 2026

Primary completion

Jul 27, 2026

Study completion Jul 27, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 26, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main purpose of this study is to compare 3 different forms of LY4065967 - a tablet and 2 types of capsule - to see how much and how quickly each gets into the bloodstream after it is swallowed, and to check for any side effects. For each participant, the study will last about 7 weeks and will include 3 stays in the Clinical Research Unit (CRU). Each stay will last 3 nights.

Conditions

  • Healthy

Interventions

  • LY4065967 TabletDrug

    Administered orally

  • LY4065967 Formulated CapsuleDrug

    Administered orally

  • LY4065967 CapsuleDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY4065967Time frame: Baseline Up to Day 17
  2. PK: Area Under the Concentration Versus Time Curve from Time Zero to Time t [AUC(0- tlast)]Time frame: Baseline Up to Day 17
  3. PK: Area Under the Concentration Versus Time Curve from Time Zero to Infinity [AUC(0-∞)]Time frame: Baseline Up to Day 17

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Fortrea Clinical Research Unit

    Daytona Beach, Florida

  • Fortrea Clinical Research Unit

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.